NPI registry status
Active
2026 NPPES data Otology & Neurotology Physician NPI 1528301330
Verify on CMS → Ariel Grobman
Otology & Neurotology Physician in Miami, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 344 in Otology & Neurotology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 469 beneficiaries · Otology & Neurotology Physician avg: 421
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
87.6/100
▲ 4 pts above national avg 83.5 · Above neutral
Industry payments
$87.5
3 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Ariel Grobman reported a CMS MIPS final score of 87.6/100 - above the 83.5 national average - and filed 1,026 Medicare Part D claims in 2024.
- 87.6/100
- MIPS score · +4 vs avg
- 1K
- Part D claims, 2024
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Ariel Grobman
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1528301330), first enumerated 03/29/2013.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,026 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 87.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$87.5 in reported industry payments (3 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Ariel Grobman's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1528301330 · Otology & Neurotology Physician
NPI-10 · ENUM-MID · TAX-TRACE · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1528301330
- ENUM-MID 2013
- TAX-TRACE 344
- MIPS-ABOVE 87.6/100
- RX-MID 1,026
- BOOK-THIN 28 in Florida
- PHOTO-FINISH Mark Lorenz · ±0.5
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Mark Lorenz · lo…
Mark Lorenz
87.1 MIPS pts
- Miriam Redleaf ·…
Miriam Redleaf
87.1 MIPS pts
- Heather Weinreic…
Heather Weinreich
87.1 MIPS pts
- Grobman · this p…
Grobman · this provider
87.6 MIPS pts
- Douglas Chen · h…
Douglas Chen
88.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Ariel Grobman's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
88 ≥ 52nd percentile 52% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ariel Grobman sits
This provider among otology & neurotology physician peers
Across the 113 otology & neurotology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Ariel Grobman writes more Part D claims than 92% of them and scores higher on MIPS quality than 62% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one otology & neurotology physician peer from a representative sample of 60; the gold marker is Ariel Grobman. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Ariel Grobman practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ariel Grobman?
High performer (top quartile)Primary specialty
Otology & Neurotology Physician
Medicare Part D claims
1,026 144% vs specialty avg
MIPS final score
87.6/100 4.1 pts vs avg
Specialty distribution in Florida
How Otology & Neurotology Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Ariel Grobman's 2023 MIPS final score plotted against the Otology & Neurotology Physician national average
- MIPS Final Score
- 87.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1528301330 |
|---|---|
| Specialty | Otology & Neurotology Physician |
| Gender | Male |
| NPI Issued | 03/29/2013 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
87.5908
Final Score
Measured-score avg: 83.5
82.3468
Quality
91
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Ariel Grobman bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Florida Ent Associates Inc
Miami, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ariel Grobman. Source: openpaymentsdata.cms.gov.
Total received
$88
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Ariel Grobman. To verify Ariel Grobman's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Ariel Grobman - brand share 19.0%
Otology & Neurotology Physician average
19% brand-name claims vs 81% generic, on 1,026 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,026
Total Claims
$41K
Total Drug Cost
469
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,259.367
- Total Day Supply
- 26,697
- Brand vs Generic
- 19% brand / 81% generic
- Brand Drug Cost
- $21K
- Generic Drug Cost
- $20K
- Opioid Claims
- 21 (2.0% rate)
- Antibiotic Claims
- 99
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 1.50
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 36, 65-74: 228, 75-84: 153, 85+: 52
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Ariel Grobman prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ipratropium Bromide
Ipratropium Bromide
148 claims
- Azelastine Hcl
Azelastine Hcl
127 claims
- Prednisolone Acetate
Prednisolone Acetate
126 claims
- Tobramycin-Dexamet…
Tobramycin-Dexamethasone
117 claims
- Ofloxacin
Ofloxacin
68 claims
- Amoxicillin-Clavul… 48
Amoxicillin-Clavulanate Potass
48 claims
- Prednisone 43
Prednisone
43 claims
- Mupirocin 38
Mupirocin
38 claims
| Drug | Claims |
|---|---|
| Ipratropium Bromide | 148 |
| Azelastine Hcl | 127 |
| Prednisolone Acetate | 126 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 117 |
| Ofloxacin | 68 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 48 |
| Prednisone | 43 |
| Mupirocin | 38 |
| Diazepam | 27 |
| Methylprednisolone | 24 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otology & Neurotology Physician Overview
How Ariel Grobman fits within the Otology & Neurotology Physician landscape nationally.
344
Otology & Neurotology Physician Providers in US
47
States with Otology & Neurotology Physician
421
Avg Claims per Provider
Ariel Grobman's 1,026 claims are above the specialty average of 421.
Nationwide Otology & Neurotology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Grobman, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (87.6 here).
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otology & Neurotology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Grobman.
One of 28 Otology & Neurotology Physician providers enrolled in Florida, 5 are shown here.
Dr. Kyle Allen
MD
Tampa, FL
Dr. Ali Alqassim
MD
Miami, FL
Dr. Simon Angeli
MD
Miami, FL
Dr. Alberto Arteaga Useche
MD
Jacksonville, FL
Dr. Loren Bartels
M.D.
Tampa, FL
Compare Otology & Neurotology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ariel Grobman's specialty? ▼
Ariel Grobman specializes in Otology & Neurotology Physician and practices in Miami, Florida.
How much does Ariel Grobman prescribe under Medicare Part D? ▼
In 2024, Ariel Grobman wrote 1,026 Medicare Part D claims totaling $41K in drug costs for 469 beneficiaries.
What is Ariel Grobman's Medicare quality score? ▼
Ariel Grobman has a CMS MIPS Final Score of 87.6/100 (Quality: 82.3). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Ariel Grobman located? ▼
Ariel Grobman is located at 3661 S MIAMI AVE STE 409, Miami, FL, 33133. Phone: (905) 854-5971.
What is Ariel Grobman's NPI number? ▼
Ariel Grobman's National Provider Identifier (NPI) is 1528301330, issued on 03/29/2013.
Does Ariel Grobman prescribe more brand-name or generic drugs? ▼
Ariel Grobman's prescribing is 19% brand-name and 81% generic drugs by claim count, with $21K in brand drug costs.
Does Ariel Grobman prescribe opioids? ▼
Yes, Ariel Grobman had 21 opioid claims in 2024 with an opioid prescribing rate of 2.0%.
How many Otology & Neurotology Physician providers are there in the US? ▼
There are 344 Otology & Neurotology Physician providers across 47 states in the US. The average Otology & Neurotology Physician provider writes 421 Medicare Part D claims per year.
What drugs does Ariel Grobman prescribe most often? ▼
Based on 2024 Medicare Part D data, Ariel Grobman's most frequently prescribed drugs include Ipratropium Bromide, Azelastine Hcl, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ariel Grobman accept Medicare? ▼
Ariel Grobman appears in CMS Medicare data with 1,026 Part D claims and 469 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ariel Grobman's credentials? ▼
Ariel Grobman's NPI is 1528301330. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.